It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
The product is indicated for the chronic management of patients with Urea Cycle Disorders
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
Subscribe To Our Newsletter & Stay Updated
